Pharma giant makes £150m acquisition
Burton-based Clinigen Group is set to buy Newcastle-based Quantum Pharma for £150.3m.
Clinigen says that Quantum's capabilities in Continental Europe will enable it to develop and further expand its European footprint.
Shaun Chilton, chief executive of Clinigen, said: "The earnings enhancing acquisition of Quantum is an excellent operational and geographical, as well as cultural, fit with Clinigen.
"Quantum's UL2L capabilities will provide a bridge between our unlicensed and commercial businesses, mirroring our business in t... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
